Delivery Order SPE2DB22D2007-SPE2DB24FJ2AE
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of 120 tablets of the pharmaceutical product NUBEQA 300 MG, with a potential value of $7,036.80 and a completion date of March 26, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $10,920.00 and a completion date of February 24, 2025. The contract is for the delivery of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NUBEQA 300 MG TABLET 120S, a pharmaceutical product, with a firm fixed price of $7,641.98 and a completion date of July 22, 2025. The contract is not set-aside and allows for the delivery of a variety of pharmaceutical and medical products to support federal agencies, particularly...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,071,825 units of the pharmaceutical product NUBEQA 300 MG TABLET 120S. The delivery order, valued at $3,518.40, has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, which...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUBEQA 300 MG TABLET 120S. The contract has a ceiling value of $7,641.98 and a completion date of July 10, 2025. It is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,640.00 contract is for the delivery of NUBEQA 300 MG TABLET 120S, a pharmaceutical product, with a performance period ending on June 20, 2025. The contract is not set-aside and was awarded on May 29, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of NUBEQA 300 MG TABLET 120S. The contract has a ceiling value of $7,641.98 and is a firm fixed-price delivery order contract, with a completion date of July 21, 2025. The contract is not set-aside and was awarded on June 27, 2025. Amerisourcebergen Drug Corp is a for-profit organization based in...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NUBEQA 300 MG TABLET 120S, a pharmaceutical product, with a ceiling value of $7,641.98 and a performance period ending on May 27, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $3,518.40 contract is for the delivery of 120 tablets of the pharmaceutical product NUBEQA 300 MG to support U.S. military treatment programs and facilities. This order is issued under Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA,...
- This is a $7,641.98 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NUBEQA 300 MG TABLET 120S, a pharmaceutical product, with a period of performance through July 23, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FJ2AEDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $3,518.40, is for the supply of the prescription drug NUBEQA 300 MG TABLET 120S. The contract has a completion date of May 20, 2024 and is a firm fixed price, delivery order type contract. This contract is not set aside for any socioeconomic program. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 4/29/24 |